CARMEL, Ind., Sept. 12, 2023 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies that ...
Achieves significant expansion of NeurAxis’ total addressable market Clearance now includes patients aged "8 years and older” Expanded age indication will utilize the upcoming January 1st, 2026, ...
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する